Sponsor Pipeline

Immuno Cure Holding (HK) Limited Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
Active Trials by Phase
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07530198 HIV Therapeutic DNA Vaccine (ICVAX) Phase I Clinical Trial in Hong Kong Human Immunodeficiency Virus Recruiting
Get alerts when Immuno Cure Holding (HK) Limited's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free